drugset
drugset / Trial / NCT02991404

Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty

NCT02991404 ↗

Phase 0 Completed 60 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

Patients undergoing Primary Total Knee Arthroplasty will be randomized to receive either multimodal single injection adductor canal block with sham infusion catheter or continuous infusion of local anesthetic (control) for postoperative analgesia. Primary end point is pain scores at 30 hours post performance of block procedure.

Timeline

Start
2017-02-17
Primary completion
2017-11-15
Completion
2017-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.125 % Other
Subject Bupivacaine Other / unclassified 0.25 % Other
Background Clonidine Other / unclassified 1.67 ug/ml Other
Background Epinephrine Other / unclassified — Other

Indications

No indication recorded.